false
OasisLMS
Catalog
Approaches to Conversations About Long-Acting Inje ...
Presentation And Q&A
Presentation And Q&A
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Dr. John Torres, the Director of Digital Psychiatry at Beth Israel Deaconess Medical Center, and technology expert for SMI Advisor, introduces a webinar titled "Approaches to Conversations About Long-Acting Injectable Antipsychotics." The webinar is part of the Clinical Support System for Serious Mental Illness initiative, which aims to provide evidence-based care for those with serious mental illness. Dr. Torres introduces the faculty for the webinar: Donna Rowland, a Clinical Associate Professor and Director of Psychiatric Mental Health Nurse Practitioner Training at the University of Texas; Sarah McLaurin, a Psychiatric Mental Health Nurse Practitioner at the Freedom Trail Clinic in Boston; Eric Atchis, a staff psychiatrist and researcher holding appointments at various healthcare services in Michigan; and Dr. Rob Cotis, an Associate Professor at Emory University School of Medicine. The panel discusses the research on long-acting injectable antipsychotics and their benefits and concerns from both patient and clinician perspectives. They also discuss the importance of shared decision-making and motivational interviewing when discussing these medications with patients. The panel also presents findings from the pre-lapse trial, which studied the use of aripiprazole monohydrate, a long-acting injectable, in early phase schizophrenia. The trial found that the use of aripiprazole monohydrate delayed the need for inpatient psychiatric hospitalization in patients with early phase schizophrenia. The panel provides guidance on addressing common concerns about long-acting injectable medications and emphasizes the importance of regular medication adherence in preventing relapse. They also discuss the challenges of transportation and engaging families in the treatment process. The panel concludes by highlighting the benefits of long-acting injectable medications and offering recommendations for incorporating them into clinical practice.
Keywords
Dr. John Torres
Director of Digital Psychiatry
Beth Israel Deaconess Medical Center
SMI Advisor
Long-Acting Injectable Antipsychotics
Clinical Support System for Serious Mental Illness
Donna Rowland
Sarah McLaurin
Eric Atchis
Dr. Rob Cotis
×
Please select your language
1
English